INVASIVE BLADDER-CANCER - (STAGE PT3B, PT4A, PN1, PN2) - REPLY

被引:0
|
作者
STOCKLE, M
机构
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:87 / 88
页数:2
相关论文
共 50 条
  • [31] ANALYSIS BY STEP SECTIONING OF EARLY INVASIVE BLADDER-CANCER WITH SPECIAL REFERENCE TO G3.PT1 DISEASE
    KAKIZOE, T
    TOBISU, K
    MIZUTANI, T
    TSUTSUMI, M
    TANAKA, Y
    SAKAMOTO, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (12): : 1354 - 1358
  • [32] Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma
    Reyal, Fabien
    Hajage, David
    Savignoni, Alexia
    Feron, Jean-Guillaume
    Bollet, Marc Andrew
    Kirova, Youlia
    Fourquet, Alain
    Pierga, Jean-Yves
    Cottu, Paul
    Dieras, Veronique
    Fourchotte, Virginie
    Laki, Fatima
    Alran, Severine
    Asselain, Bernard
    Vincent-Salomon, Anne
    Sigal-Zafrani, Brigitte
    Sastre-Garau, Xavier
    PLOS ONE, 2013, 8 (03):
  • [33] Effectiveness of adjuvant chemotherapy (AC) versus observation in patients with ≥pT3 and/or pN+ bladder cancer (BCa)
    Galsky, Matt D.
    Stensland, Kristian
    Moshier, Erin L.
    Sfakianos, John
    McBride, Russell Bailey
    Tsao, Che-Kai
    Casey, Martin Francis
    Hall, Simon J.
    Boffetta, Paolo
    Oh, William K.
    Wisnivesky, Juan P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] MANAGEMENT OF SUPERFICIAL G2(PTA AND PT1) BLADDER-CANCER
    THORPE, AC
    JENKINS, BJ
    MARTIN, JE
    UROLOGY, 1990, 36 (05) : 395 - 397
  • [35] DOES A STAGE PT0 CYSTECTOMY SPECIMEN CONFER A SURVIVAL ADVANTAGE IN PATIENTS WITH MINIMALLY INVASIVE BLADDER-CANCER
    THRASHER, JB
    FRAZIER, HA
    ROBERTSON, JE
    PAULSON, DF
    JOURNAL OF UROLOGY, 1994, 152 (02): : 393 - 396
  • [36] ELECTRONIC AND RESONANCE-RAMAN SPECTRA OF THE LINEAR-CHAIN MIXED-VALENCE PLATINUM COMPLEXES ([PT(EN)2][PT(EN)2X2])3[CUX4]4 [X=CL (1) OR BR (2)] AND [PT(PN)2][PT(PN)BR2][CU3BR5]2 (3) (EN = ETHANE-1,2-DIAMINE AND PN = PROPANE-1,2-DIAMINE)
    CLARK, RJH
    KURMOO, M
    KELLER, HJ
    KEPPLER, B
    TRAEGER, U
    JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1980, (12): : 2498 - 2502
  • [37] Comparative effectiveness of adjuvant chemotherapy (AC) versus observation in patients with ≥ pT3 and/or pN+ bladder cancer (BCa).
    Galsky, Matt D.
    Stensland, Kristian
    Moshier, Erin L.
    Sfakianos, John
    McBride, Russell Bailey
    Tsao, Che-Kai
    Casey, Martin Francis
    Hall, Simon J.
    Boffetta, Paolo
    Oh, William K.
    Wisnivesky, Juan P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [38] Nucleolin and Nucleophosmin Expression in Gleason 3 and Gleason 4 Prostate Cancer With Seminal Vesicles Invasion (pT3b)
    Masiuk, Marek
    Lewandowska, Magdalena
    Dobak, Ewa
    Urasinska, Elzbieta
    ANTICANCER RESEARCH, 2020, 40 (04) : 1973 - 1979
  • [39] Adjuvant radiotherapy after mastectomy for pT1-pT2 node negative (pN0) breast cancer: is it worth the effort?
    Voordeckers, M
    Van de Steene, J
    Vinh-Hung, V
    Storme, G
    RADIOTHERAPY AND ONCOLOGY, 2003, 68 (03) : 227 - 231
  • [40] PATIENTS WITH LOW RISK FEATURES, OMITTED PELVIC LYMPH NODE DISSECTION (PLND) BUT PATHOLOGICALLY LOCALLY ADVANCED PROSTATE CANCERS (PT3A/PT3BNX) HAVE A BETTER ONCOLOGICAL OUTCOME THAN THEIR PT3A/PT3B PN0-COUNTERPARTS
    Garm, Jens
    Tennstedt, Pierre
    Huland, Hartwig
    Heinzer, Hans
    Graefen, Markus
    Haese, Alexander
    JOURNAL OF UROLOGY, 2012, 187 (04): : E281 - E281